Overall rank by patents
#49,854
of 49,997 tracked assignees
USPTO PatentsView assignee record - 5 granted patents across 5 technology areas, recorded in grant years 2020–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C30B (Single-crystal Growth ; Unidirectional Solidification OF Eutectic Material OR Unidirectional Demixing OF Eutectoid MATERIAL; Refining BY Zone-melting OF Material ; Production OF A Homogeneous Polycrys).
The verdict
According to USPTO PatentsView, PVA ranks #49,854 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 5 technology areas.
USPTO PatentsView assignee plate
Corpus R49854 · Foreign Corporation #49,854 · 5 grants
GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH
Nearest grant-volume peer: Pacaso Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
PVA Tepla · this assignee
28 score
3D Lighting… · lowest
7 score
What this shows PVA's Innovation Score is 28.3/100 (27th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
PVA Tepla AG is a focused PatentsView assignee: 5 CPC subclasses with 60% of grants classified under C30B (Single-crystal Growth ; Unidirectional Solidification OF Eutectic Material OR Unidirectional Demixing OF Eutectoid MATERIAL; Refining BY Zone-melting OF Material ; Production OF A Homogeneous Polycrys). By volume, PVA sits between Puget Sound Blood Center and Pacific Berry Breeding.
PVA Tepla AG shows 1 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Puget Sound Blood Center
5 patents
Pulmonary Apps, LLC
5 patents
Pure AIR Filtration, LLC.
5 patents
PV Fluid Products, Inc.
5 patents
PVH Corporation
5 patents
PacSeal Group, Inc.
5 patents
Pacaso Inc.
5 patents
Pacific Berry Breeding
5 patents
PVA Tepla AG
5 patents
What this shows PVA holds 5 patents at rank #49,640, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #49,640 in granted patent volume.
Other assignees with the most granted patents in PVA's primary technology class.
PVA's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
28 27th percentile higher than 27% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2020 | 1 | 20.0% |
| 2024 | 1 | 20.0% |
| 2025partial year | 3 | 60.0% |
Top 5 of 5 technology areas
Overall rank by patents
#49,854
of 49,997 tracked assignees
28.3 out of 100
What to do with this data
PVA Tepla AG's patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.